abstract |
PHARMACEUTICAL COMPOSITION. The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing the compound {1S- [1 (alpha), 2 (alpha), 3 (beta) (1S *, 2R *), 5 (beta)] } -3- (7 - {[2- (3,4-1) cyclopropyl] amino} -5- (propylthio) -3H-1,2,3-triazo1 [4,5-d] yl) -5- (2-hydroxyethoxy) cyclopentane-1,2-diol. |